In this episode, Dr. Justin Gatwood, who is a health services researcher and Assistant Professor at the University of Tennessee College of Pharmacy in Nashville, TN, shares about a new national initiative between UTCOP and Kroger to help increase shingles vaccine rates.
Two shingles vaccines are licensed and recommended in the United States. Zoster vaccine live (ZVL, Zostavax) has been used since 2006, and recombinant zoster vaccine (RZV, Shingrix), has been used since 2017, and is recommended as the preferred shingles vaccine.
· Overview of the Kroger/UT vaccine program that focuses on Shingrix dose completion: justification, approach, and expected impact
· How this project contributes to the larger role of pharmacy and pharmacists in providing public health services
· Parallel projects at UT focusing on improving vaccination rates in adults by leveraging community pharmacists
· Lessons learned from addressing and expected challenges of expanding vaccination in community pharmacies
Host – Hillary Blackburn, PharmD, MBA
@talktoyourpharmacist for Instagram and Facebook